Insulin-like growth factors and breast cancer risk in Chinese women

Cancer Epidemiology Biomarkers and Prevention

Volumn 11, Issue 8, 2002, Pages 705-712

  Yu, Herbert ^a   Jin, Fan ^d   Shu, Xiao Ou ^c   Li, Benjamin D L ^b   Dai, Qi ^c   Cheng, Jia Rong ^d   Berkel, Hans J ^b   Zheng, Wei ^c  

^a YALE CANCER CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c VANDERBILT INGRAM CANCER CENTER   (United States)

^d SHANGHAI CANCER INSTITUTE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ANTHROPOMETRY; ARTICLE; BODY MASS; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHINA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MIDDLE AGED; ODDS RATIO; REGRESSION ANALYSIS; RISK FACTORS;

EID: 0036327474     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Role of the insulin-like growth factor family in cancer development and progression
2. The effects of insulin-like growth factors on tumorigenesis and neoplastic growth
3. Insulin-like growth factors and their binding proteins
4. Insulin-like growth factors and their binding proteins: Biological actions
5. Somatomedin-C receptors and growth effects in human breast cells maintained in long-term tissue culture
6. Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17b-estradiol
7. Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor
8. Insulin-like growth factor 1 (IGF-I) alters drug sensitivity of HBL 100 human breast cancer cells by inhibition of apoptosis induced by diverse anticancer drugs
9. Insulin-like growth factor (IGF)-I rescues breast cancer cells from chemotherapy-induced cell death-proliferative and anti-apoptotic effects
10. Role of insulin-like growth factor and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells
11. Oestradiol treatment increases the sensitivity of MCF-7 cells for the growth stimulatory effect of IGF-I
12. Estradiol and antiestrogens regulate a growth inhibitory insulin-like growth factor binding protein 3 autocrine loop in human breast cancer cells
13. Energy intake and prostate tumor growth, angiogenesis, and vascular endothelial growth factor expression
14. Dietary restriction reduces insulin-like growth factor 1 levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice
15. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer
16. Insulin-like growth-factor binding protein 3 is decreased in early-stage operable pre-menopausal breast cancer
17. Insulin-like growth factor-I in relation to premenopausal ductal carcinoma in situ of the breast
18. Serum insulin-like growth factor-I and breast cancer
19. Insulin-like growth factor-I and breast cancer risk in postmenopausal African-American women
20. Plasma insulin-like growth factor (IGF) I. IGF-binding protein 3, and mammographic density
21. Association of menstrual and reproductive factors with breast cancer risk: Results from the Shanghai breast cancer study
22. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study
23. IGF-I IGF-II in relation to colorectal cancer
24. Insulin-like growth factors (IGF-I, free IGF-I, and IGF-II) and insulin-like growth factor binding proteins (IGFBP-2. IGFBP-3, IGFBP-6, and ALS) in blood circulation
25. Insulin and related factors in premenopausal breast cancer risk
26. Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: A prospective study
27. Serum c-peptide, insulin-like growth factor (IGF)-I. IGF-binding proteins, and colorectal cancer risk in women
28. Associations between insulin-like growth factors and their binding proteins and other prognostic indicators in breast cancer
29. Correlation of insulin-like growth factor-binding protein-3 messenger RNA with protein expression in primary breast cancer tissues: Detection of higher levels in tumors with poor prognostic features
30. Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: Correlation with clinical parameters and disease-free survival
31. Insulin-like growth factor-binding protein-3 and breast cancer survival
32. IGFBP-3 in epithelial ovarian carcinoma and its association with clinico-pathological features and patients survival
33. The role of the insulin-like growth factor binding proteins and the IGFBP proteases in modulating IGF action
34. Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics
35. Insulin-like growth factor binding proteins and their role in controlling IGF actions
36. Growth, differentiation, and survival: Multiple physiological functions for insulin-like growth factors
37. Serum insulin-like growth factors I and II concentrations and growth hormone and insulin responses to arginine infusion in children with protein-energy malnutrition before and after nutritional rehabilitation
38. Effects of zinc and other nutritional factors on insulin-like growth factor I and insulin-like growth factor binding proteins in postmenopausal women
39. Effects of caloric or protein restriction on insulin-like growth factor-I (IGF-I) and IGF-binding proteins in children and adults
40. Effect of dietary protein deprivation on insulin-like growth factor (IGF)-I and -II. IGF binding protein-2, and serum albumin gene expression in rat
41. Reduced serum concentrations of insulin-like growth factor-I (IGF-I) in protein-restricted growing rats are accompanied by reduced IGF-I mRNA levels in liver and skeletal muscle
42. Nutritional regulation of the insulin-like growth factors